CareDx Inc
NASDAQ:CDNA

Watchlist Manager
CareDx Inc Logo
CareDx Inc
NASDAQ:CDNA
Watchlist
Price: 18.76 USD -0.37% Market Closed
Market Cap: 1B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+7%
Revenue
Forecast
+20%
Operating Income
Forecast
+32%
Net Income
Forecast
-45%

Wall Street
Price Targets

CDNA Price Targets Summary
CareDx Inc

Wall Street analysts forecast CDNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for CDNA is 29.2 USD with a low forecast of 19.19 USD and a high forecast of 42 USD.

CDNA Lowest Forecast
Wall Street Target
19.19 USD
2% Upside
CDNA Average Forecast
Wall Street Target
29.2 USD
56% Upside
CDNA Highest Forecast
Wall Street Target
42 USD
124% Upside
Lowest
Price Target
19.19 USD
2% Upside
Average
Price Target
29.2 USD
56% Upside
Highest
Price Target
42 USD
124% Upside
CareDx Inc Competitors:
Price Targets
BEAM
Beam Therapeutics Inc
165% Upside
SWTX
SpringWorks Therapeutics Inc
14% Upside
V
VTGN
VistaGen Therapeutics Inc
473% Upside
EXEL
Exelixis Inc
0% Upside
BEAM
Beam Therapeutics Inc
165% Upside
SWTX
SpringWorks Therapeutics Inc
14% Upside
V
VTGN
VistaGen Therapeutics Inc
473% Upside
EXEL
Exelixis Inc
0% Upside
PRLD
Prelude Therapeutics Inc
268% Upside
S
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
13% Downside
TECX
AVROBIO Inc
276% Upside
SNDX
Syndax Pharmaceuticals Inc
253% Upside

Revenue
Forecast

Revenue Estimate
CareDx Inc

For the last 8 years the compound annual growth rate for CareDx Inc's revenue is 30%. The projected CAGR for the next 3 years is 14%.

30%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
CareDx Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
98%
Average Beat
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
CareDx Inc

The compound annual growth rate of CareDx Inc's net income for the next 3 years is 15%.

N/A
Past Growth
15%
Estimated Growth
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
CDNA intrinsic value, competitors valuation, and company profile.
DCF Valuation
CDNA stock valuation using Discount Cash Flow valuation method.
Relative Valuation
CDNA stock valuation using valuation multiples.
Wall Street Estimates
CDNA price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
CDNA stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is CDNA's stock price target?
Price Target
29.2 USD

According to Wall Street analysts, the average 1-year price target for CDNA is 29.2 USD with a low forecast of 19.19 USD and a high forecast of 42 USD.

What is CareDx Inc's Revenue forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for CareDx Inc's revenue is 30%. The projected CAGR for the next 3 years is 14%.

What is CareDx Inc's Net Income forecast?
Projected CAGR
15%

The compound annual growth rate of CareDx Inc's net income for the next 3 years is 15%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 261,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.